Pathology Nucleus is a physician-led pathology group supporting AI, pharmaceutical, biotech and CRO partners. We work at the intersection of medicine, data and technology to deliver clinically robust, regulator-ready outputs for AI development and early-phase translational research. We specialise in AI-ready datasets, regulatory-grade QC and central pathology review.

Consultant governed datasets and workflows for scalable clinical AI development.
Annotation Frameworks
Design and validation of tumour boundaries, grading systems, and biomarker protocols to generate regulator ready AI training datasets.
Clinical QA Oversight
Consultant pathologist governance and sign off to ensure annotations are accurate, reproducible, and clinically defensible for AI validation and regulatory submission.
Strategic CRO and Pharma Support
End to end annotation and dataset strategy for pharmaceutical, CRO, and biotech clients building hybrid human AI pathology pipelines.

Specialist consultant led pathology to support regulated clinical research.
Clinical Trial Pathology
Central pathology review of biopsies and trial specimens to support endpoint assessment and regulatory reporting.
Biomarker Analysis
Predictive and prognostic biomarker evaluation with study ready reporting for targeted therapy development.
AI Ready Research Datasets
Generation of high quality research datasets compatible with AI model development and translational research pipelines.
Consultant pathologists with GMC and ABPath certification delivering regulator ready pathology for AI and clinical trials.








Pathology Nucleus